Showing results (1-10 of 70) with videos related to
Sort By:
Pageof 7
Journal of UOEH|December 16, 2014
New therapeutic strategy for hepatocellular carcinoma by molecular targeting agents via inhibition of cellular stress defense mechanismsYuichi Honma, Masaru HaradaExperimental Cell Research|June 4, 2013
Sorafenib enhances proteasome inhibitor-mediated cytotoxicity via inhibition of unfolded protein response and keratin phosphorylationYuichi Honma, Masaru HaradaExperimental Cell Research|August 10, 2016
Copper induces hepatocyte injury due to the endoplasmic reticulum stress in cultured cells and patients with Wilson diseaseShinji Oe, Koichiro Miyagawa, Yuichi Honma, et al.Journal of Gastroenterology|April 2, 2013
Sorafenib enhances proteasome inhibitor-induced cell death via inactivation of Akt and stress-activated protein kinasesYuichi Honma, Satoshi Shimizu, Tetsuo Takehara, et al.Internal Medicine (Tokyo, Japan)|October 14, 2024
Tocilizumab, a Humanized Anti-interleukin-6 Receptor Antibody, Induces Hepatic Iron Overload in a Susceptible PatientMasaru Harada, Yuichi Honma, Eisuke Shiba, et al.Internal Medicine (Tokyo, Japan)|August 4, 2017
Reactivation of Occult Hepatitis B Virus Infection 27 Months after the End of Chemotherapy Including Rituximab for Malignant LymphomaJunichi Muraishi, Michihiko Shibata, Yuichi Honma, et al.Case Reports in Gastrointestinal Medicine|July 28, 2026
Cholecystocolonic Fistula Associated With Advanced Mirizzi Syndrome Causing Chronic Diarrhea: Successful Treatment Using Cholangioscopy-Guided Lithotripsy and SurgeryKoichiro Miyagawa, Daiki Uchihara, Shinji Oe, et al.The American Journal of Pathology|May 10, 2016
Lipid-Induced Endoplasmic Reticulum Stress Impairs Selective Autophagy at the Step of Autophagosome-Lysosome Fusion in HepatocytesKoichiro Miyagawa, Shinji Oe, Yuichi Honma, et al.Cancers|November 4, 2020
Antiplatelet Therapy Improves the Prognosis of Patients with Hepatocellular CarcinomaTsuguru Hayashi, Michihiko Shibata, Shinji Oe, et al.Plos One|December 22, 2020
C-reactive protein can predict dose intensity, time to treatment failure and overall survival in HCC treated with lenvatinibTsuguru Hayashi, Michihiko Shibata, Shinji Oe, et al.Pageof 7